How can mitochondrial DNA deletions act as a biomarker for the detection of endometriosis within the clinic?
[...]recently, the function of the mitochondrial genome was thought to be limited to its role in energy production, however continued research reveals that the complexity of this small DNA was vastly underestimated and roles in disease initiation, progression and intercellular communication are amon...
Gespeichert in:
Veröffentlicht in: | Biomarkers in medicine 2020-01, Vol.14 (1), p.5-8 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 8 |
---|---|
container_issue | 1 |
container_start_page | 5 |
container_title | Biomarkers in medicine |
container_volume | 14 |
creator | Creed, Jennifer M Maggrah, Andrea Usher, Robert Desa, Elise Harbottle, Andrew |
description | [...]recently, the function of the mitochondrial genome was thought to be limited to its role in energy production, however continued research reveals that the complexity of this small DNA was vastly underestimated and roles in disease initiation, progression and intercellular communication are among its critical functions (8). Typically, tens to hundreds of mtDNAs exist in each cell - in contrast to the one or two copies of the nuclear genome. [...]while the mass of DNA in a cell is >99.9% nuclear in origin, the difference in copy number is significant. [...]patients with a presumptive diagnosis of endometriosis who are considering laparoscopy for treatment purposes can benefit from a confirmatory biomarker test, wherein a diagnostic cut-off selected for high specificity and in turn low false-positive rate could aid in prevention of unnecessary surgery. [...]as severity of symptoms poorly parallels the severity of endometriosis, absence of return of symptoms may fail to alert patient and physician to progressing disease, a disconnect that can have a dire effect on pelvic health and fertility. |
doi_str_mv | 10.2217/bmm-2019-0435 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2339637881</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2339637881</sourcerecordid><originalsourceid>FETCH-LOGICAL-c410t-212464a69b9930e393283004b3583884bfb5208f1d84d241bec322e18a973c673</originalsourceid><addsrcrecordid>eNp1kMtLxDAQh4Mo7vo4epWA52pebdOTLOsTRC96Dm06ZaNtsiYpi_-9qat78zQz8M1vmA-hM0ouGaPlVTMMGSO0yojg-R6a0zJnGeEl3d_1BZ-hoxDeCcnLsmCHaMZpIYtcyDnqH9wG69riwUSnV8623tQ9vnle4BZ6iMbZgGsdcZ0Kbowbav8BHnfO47iCBEXQE4Vdh8G2boDojQsm4I2JK2N_KN0ba_T1CTro6j7A6W89Rm93t6_Lh-zp5f5xuXjKtKAkZowyUYi6qJqq4gR4xZnkhIiG55JLKZquyRmRHW2laJmgDWjOGFBZVyXXRcmP0cU2d-3d5wghqnc3eptOKsZ5VfBSSpqobEtp70Lw0Km1N-m9L0WJmtyq5FZNbtXkNvHnv6ljM0C7o_9kJqDaAt0YRw9BG7Aa1HZKG0YbC_-EfwPe7oci</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2339637881</pqid></control><display><type>article</type><title>How can mitochondrial DNA deletions act as a biomarker for the detection of endometriosis within the clinic?</title><source>MEDLINE</source><source>PubMed Central</source><creator>Creed, Jennifer M ; Maggrah, Andrea ; Usher, Robert ; Desa, Elise ; Harbottle, Andrew</creator><creatorcontrib>Creed, Jennifer M ; Maggrah, Andrea ; Usher, Robert ; Desa, Elise ; Harbottle, Andrew</creatorcontrib><description>[...]recently, the function of the mitochondrial genome was thought to be limited to its role in energy production, however continued research reveals that the complexity of this small DNA was vastly underestimated and roles in disease initiation, progression and intercellular communication are among its critical functions (8). Typically, tens to hundreds of mtDNAs exist in each cell - in contrast to the one or two copies of the nuclear genome. [...]while the mass of DNA in a cell is >99.9% nuclear in origin, the difference in copy number is significant. [...]patients with a presumptive diagnosis of endometriosis who are considering laparoscopy for treatment purposes can benefit from a confirmatory biomarker test, wherein a diagnostic cut-off selected for high specificity and in turn low false-positive rate could aid in prevention of unnecessary surgery. [...]as severity of symptoms poorly parallels the severity of endometriosis, absence of return of symptoms may fail to alert patient and physician to progressing disease, a disconnect that can have a dire effect on pelvic health and fertility.</description><identifier>ISSN: 1752-0363</identifier><identifier>EISSN: 1752-0371</identifier><identifier>DOI: 10.2217/bmm-2019-0435</identifier><identifier>PMID: 31686548</identifier><language>eng</language><publisher>England: Future Medicine Ltd</publisher><subject>biomarker ; Biomarkers ; Biomarkers - analysis ; Cell signaling ; Copy number ; Deoxyribonucleic acid ; Disease ; Disease Progression ; DNA ; DNA deletion ; DNA, Mitochondrial - analysis ; DNA, Mitochondrial - genetics ; Endometriosis ; Endometriosis - diagnosis ; Endometriosis - genetics ; Female ; Genomes ; Humans ; Infertility ; Laparoscopy ; Life sciences ; Menstruation ; Mitochondrial DNA ; molecular diagnostic ; mtDNA ; Mutation ; Patients ; Sequence Deletion ; Surgery</subject><ispartof>Biomarkers in medicine, 2020-01, Vol.14 (1), p.5-8</ispartof><rights>2019 MDNA Life Sciences Inc.</rights><rights>2020. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c410t-212464a69b9930e393283004b3583884bfb5208f1d84d241bec322e18a973c673</citedby><cites>FETCH-LOGICAL-c410t-212464a69b9930e393283004b3583884bfb5208f1d84d241bec322e18a973c673</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31686548$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Creed, Jennifer M</creatorcontrib><creatorcontrib>Maggrah, Andrea</creatorcontrib><creatorcontrib>Usher, Robert</creatorcontrib><creatorcontrib>Desa, Elise</creatorcontrib><creatorcontrib>Harbottle, Andrew</creatorcontrib><title>How can mitochondrial DNA deletions act as a biomarker for the detection of endometriosis within the clinic?</title><title>Biomarkers in medicine</title><addtitle>Biomark Med</addtitle><description>[...]recently, the function of the mitochondrial genome was thought to be limited to its role in energy production, however continued research reveals that the complexity of this small DNA was vastly underestimated and roles in disease initiation, progression and intercellular communication are among its critical functions (8). Typically, tens to hundreds of mtDNAs exist in each cell - in contrast to the one or two copies of the nuclear genome. [...]while the mass of DNA in a cell is >99.9% nuclear in origin, the difference in copy number is significant. [...]patients with a presumptive diagnosis of endometriosis who are considering laparoscopy for treatment purposes can benefit from a confirmatory biomarker test, wherein a diagnostic cut-off selected for high specificity and in turn low false-positive rate could aid in prevention of unnecessary surgery. [...]as severity of symptoms poorly parallels the severity of endometriosis, absence of return of symptoms may fail to alert patient and physician to progressing disease, a disconnect that can have a dire effect on pelvic health and fertility.</description><subject>biomarker</subject><subject>Biomarkers</subject><subject>Biomarkers - analysis</subject><subject>Cell signaling</subject><subject>Copy number</subject><subject>Deoxyribonucleic acid</subject><subject>Disease</subject><subject>Disease Progression</subject><subject>DNA</subject><subject>DNA deletion</subject><subject>DNA, Mitochondrial - analysis</subject><subject>DNA, Mitochondrial - genetics</subject><subject>Endometriosis</subject><subject>Endometriosis - diagnosis</subject><subject>Endometriosis - genetics</subject><subject>Female</subject><subject>Genomes</subject><subject>Humans</subject><subject>Infertility</subject><subject>Laparoscopy</subject><subject>Life sciences</subject><subject>Menstruation</subject><subject>Mitochondrial DNA</subject><subject>molecular diagnostic</subject><subject>mtDNA</subject><subject>Mutation</subject><subject>Patients</subject><subject>Sequence Deletion</subject><subject>Surgery</subject><issn>1752-0363</issn><issn>1752-0371</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNp1kMtLxDAQh4Mo7vo4epWA52pebdOTLOsTRC96Dm06ZaNtsiYpi_-9qat78zQz8M1vmA-hM0ouGaPlVTMMGSO0yojg-R6a0zJnGeEl3d_1BZ-hoxDeCcnLsmCHaMZpIYtcyDnqH9wG69riwUSnV8623tQ9vnle4BZ6iMbZgGsdcZ0Kbowbav8BHnfO47iCBEXQE4Vdh8G2boDojQsm4I2JK2N_KN0ba_T1CTro6j7A6W89Rm93t6_Lh-zp5f5xuXjKtKAkZowyUYi6qJqq4gR4xZnkhIiG55JLKZquyRmRHW2laJmgDWjOGFBZVyXXRcmP0cU2d-3d5wghqnc3eptOKsZ5VfBSSpqobEtp70Lw0Km1N-m9L0WJmtyq5FZNbtXkNvHnv6ljM0C7o_9kJqDaAt0YRw9BG7Aa1HZKG0YbC_-EfwPe7oci</recordid><startdate>20200101</startdate><enddate>20200101</enddate><creator>Creed, Jennifer M</creator><creator>Maggrah, Andrea</creator><creator>Usher, Robert</creator><creator>Desa, Elise</creator><creator>Harbottle, Andrew</creator><general>Future Medicine Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>EHMNL</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope></search><sort><creationdate>20200101</creationdate><title>How can mitochondrial DNA deletions act as a biomarker for the detection of endometriosis within the clinic?</title><author>Creed, Jennifer M ; Maggrah, Andrea ; Usher, Robert ; Desa, Elise ; Harbottle, Andrew</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c410t-212464a69b9930e393283004b3583884bfb5208f1d84d241bec322e18a973c673</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>biomarker</topic><topic>Biomarkers</topic><topic>Biomarkers - analysis</topic><topic>Cell signaling</topic><topic>Copy number</topic><topic>Deoxyribonucleic acid</topic><topic>Disease</topic><topic>Disease Progression</topic><topic>DNA</topic><topic>DNA deletion</topic><topic>DNA, Mitochondrial - analysis</topic><topic>DNA, Mitochondrial - genetics</topic><topic>Endometriosis</topic><topic>Endometriosis - diagnosis</topic><topic>Endometriosis - genetics</topic><topic>Female</topic><topic>Genomes</topic><topic>Humans</topic><topic>Infertility</topic><topic>Laparoscopy</topic><topic>Life sciences</topic><topic>Menstruation</topic><topic>Mitochondrial DNA</topic><topic>molecular diagnostic</topic><topic>mtDNA</topic><topic>Mutation</topic><topic>Patients</topic><topic>Sequence Deletion</topic><topic>Surgery</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Creed, Jennifer M</creatorcontrib><creatorcontrib>Maggrah, Andrea</creatorcontrib><creatorcontrib>Usher, Robert</creatorcontrib><creatorcontrib>Desa, Elise</creatorcontrib><creatorcontrib>Harbottle, Andrew</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>UK & Ireland Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><jtitle>Biomarkers in medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Creed, Jennifer M</au><au>Maggrah, Andrea</au><au>Usher, Robert</au><au>Desa, Elise</au><au>Harbottle, Andrew</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>How can mitochondrial DNA deletions act as a biomarker for the detection of endometriosis within the clinic?</atitle><jtitle>Biomarkers in medicine</jtitle><addtitle>Biomark Med</addtitle><date>2020-01-01</date><risdate>2020</risdate><volume>14</volume><issue>1</issue><spage>5</spage><epage>8</epage><pages>5-8</pages><issn>1752-0363</issn><eissn>1752-0371</eissn><abstract>[...]recently, the function of the mitochondrial genome was thought to be limited to its role in energy production, however continued research reveals that the complexity of this small DNA was vastly underestimated and roles in disease initiation, progression and intercellular communication are among its critical functions (8). Typically, tens to hundreds of mtDNAs exist in each cell - in contrast to the one or two copies of the nuclear genome. [...]while the mass of DNA in a cell is >99.9% nuclear in origin, the difference in copy number is significant. [...]patients with a presumptive diagnosis of endometriosis who are considering laparoscopy for treatment purposes can benefit from a confirmatory biomarker test, wherein a diagnostic cut-off selected for high specificity and in turn low false-positive rate could aid in prevention of unnecessary surgery. [...]as severity of symptoms poorly parallels the severity of endometriosis, absence of return of symptoms may fail to alert patient and physician to progressing disease, a disconnect that can have a dire effect on pelvic health and fertility.</abstract><cop>England</cop><pub>Future Medicine Ltd</pub><pmid>31686548</pmid><doi>10.2217/bmm-2019-0435</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1752-0363 |
ispartof | Biomarkers in medicine, 2020-01, Vol.14 (1), p.5-8 |
issn | 1752-0363 1752-0371 |
language | eng |
recordid | cdi_proquest_journals_2339637881 |
source | MEDLINE; PubMed Central |
subjects | biomarker Biomarkers Biomarkers - analysis Cell signaling Copy number Deoxyribonucleic acid Disease Disease Progression DNA DNA deletion DNA, Mitochondrial - analysis DNA, Mitochondrial - genetics Endometriosis Endometriosis - diagnosis Endometriosis - genetics Female Genomes Humans Infertility Laparoscopy Life sciences Menstruation Mitochondrial DNA molecular diagnostic mtDNA Mutation Patients Sequence Deletion Surgery |
title | How can mitochondrial DNA deletions act as a biomarker for the detection of endometriosis within the clinic? |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T23%3A34%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=How%20can%20mitochondrial%20DNA%20deletions%20act%20as%20a%20biomarker%20for%20the%20detection%20of%20endometriosis%20within%20the%20clinic?&rft.jtitle=Biomarkers%20in%20medicine&rft.au=Creed,%20Jennifer%20M&rft.date=2020-01-01&rft.volume=14&rft.issue=1&rft.spage=5&rft.epage=8&rft.pages=5-8&rft.issn=1752-0363&rft.eissn=1752-0371&rft_id=info:doi/10.2217/bmm-2019-0435&rft_dat=%3Cproquest_cross%3E2339637881%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2339637881&rft_id=info:pmid/31686548&rfr_iscdi=true |